Recent Finacing
Recent Raise
Alpine Immune Sciences develops protein-based immunotherapies using its vIgD™ platform to engineer multivalent ligands that modulate immune synapse signaling, and TIP™ transmembrane modules for engineered cell therapies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors